300404 博济医药
已收盘 10-30 15:00:00
资讯
新帖
简况
博济医药（300404）10月30日主力资金净买入1365.60万元
证券之星 · 10-30 15:32
博济医药（300404）10月30日主力资金净买入1365.60万元
博济医药（300404）10月29日主力资金净买入3078.21万元
证券之星 · 10-29 15:29
博济医药（300404）10月29日主力资金净买入3078.21万元
股市必读：博济医药三季报 - 第三季度单季净利润同比增长90.65%
证券之星 · 10-29 04:07
股市必读：博济医药三季报 - 第三季度单季净利润同比增长90.65%
10月28日博济医药涨7.29%，国证2000ETF广发基金重仓该股
证券之星 · 10-28
10月28日博济医药涨7.29%，国证2000ETF广发基金重仓该股
博济医药(300404)9月30日股东户数4.15万户，较上期增加53.54%
证券之星 · 10-27
博济医药(300404)9月30日股东户数4.15万户，较上期增加53.54%
股市必读：博济医药新发布《北京市康达律师事务所关于博济医药科技股份有限公司2026年度向特定对象发行股票的法律意见书》
证券之星 · 10-26
股市必读：博济医药新发布《北京市康达律师事务所关于博济医药科技股份有限公司2026年度向特定对象发行股票的法律意见书》
博济医药（300404）披露2026年度向特定对象发行股票募集说明书（申报稿），10月23日股价上涨0.27%
证券之星 · 10-23
博济医药（300404）披露2026年度向特定对象发行股票募集说明书（申报稿），10月23日股价上涨0.27%
博济医药(300404.SZ)定增股票申请获深交所受理
智通财经 · 10-23
博济医药(300404.SZ)定增股票申请获深交所受理
股市必读：博济医药新发布《第六届董事会第三次会议决议公告》
证券之星 · 10-13
股市必读：博济医药新发布《第六届董事会第三次会议决议公告》
博济医药（300404）9月24日主力资金净卖出1.14亿元
证券之星 · 09-24
博济医药（300404）9月24日主力资金净卖出1.14亿元
博济医药（300404）披露完成工商变更登记及备案公告，9月2日股价下跌2.24%
证券之星 · 09-02
博济医药（300404）披露完成工商变更登记及备案公告，9月2日股价下跌2.24%
博济医药：8月26日接受机构调研，中泰证券、鸿运基金等多家机构参与
证券之星 · 08-27
博济医药：8月26日接受机构调研，中泰证券、鸿运基金等多家机构参与
博济医药(300404)6月30日股东户数2.7万户，较上期减少13.4%
证券之星 · 08-26
博济医药(300404)6月30日股东户数2.7万户，较上期减少13.4%
博济医药：临床前研究服务包括药物发现、药学研究、非临床安全性评价（GLP）、药效学研究、药代动力学研究等服务
证券之星 · 08-17
博济医药：临床前研究服务包括药物发现、药学研究、非临床安全性评价（GLP）、药效学研究、药代动力学研究等服务
8月14日博济医药（300404）龙虎榜数据：机构净买入4939.99万元
证券之星 · 08-14
8月14日博济医药（300404）龙虎榜数据：机构净买入4939.99万元
8月13日博济医药（300404）龙虎榜数据：机构净买入3657.72万元
证券之星 · 08-13
8月13日博济医药（300404）龙虎榜数据：机构净买入3657.72万元
异动快报：博济医药（300404）8月13日9点57分触及涨停板
证券之星 · 08-13
异动快报：博济医药（300404）8月13日9点57分触及涨停板
生物科技板块拉升 博济医药涨超10%
南方财经网 · 08-13
生物科技板块拉升 博济医药涨超10%
博济医药（300404）披露2026年第二次临时股东大会通知，7月15日股价上涨3.12%
证券之星 · 07-15
博济医药（300404）披露2026年第二次临时股东大会通知，7月15日股价上涨3.12%
博济医药（300404）披露高级管理人员辞职公告，6月30日股价下跌2.67%
证券之星 · 06-30
博济医药（300404）披露高级管理人员辞职公告，6月30日股价下跌2.67%
加载更多
公司概况
公司名称：
博济医药科技股份有限公司
所属行业：
研究和试验发展
上市日期：
2015-04-24
主营业务：
博济医药科技股份有限公司的主营业务是为国内外制药企业及其他研究机构就新药品、医疗器械的研发与生产提供全流程“一站式”CRO服务。公司的主要产品是临床研究服务、临床前研究服务、其他咨询服务、CDMO服务、自主研发及技术成果转化。
发行价格：
12.87
{"stockData":{"symbol":"300404","market":"SZ","secType":"STK","nameCN":"博济医药","latestPrice":11.54,"timestamp":1793343816000,"preClose":11.4,"halted":0,"volume":53714855,"delay":0,"changeRate":0.0123,"floatShares":286000000,"shares":386000000,"eps":0.1501,"marketStatus":"已收盘","change":0.14,"latestTime":"10-30 15:00:00","open":11.36,"high":12.48,"low":10.54,"amount":615000000,"amplitude":0.1702,"askPrice":11.54,"askSize":740,"bidPrice":11.53,"bidSize":313,"shortable":0,"etf":0,"ttmEps":0.1501,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1793583000000},"marketStatusCode":5,"adr":0,"adjPreClose":11.4,"symbolType":"stock","openAndCloseTimeList":[[1793323800000,1793331000000],[1793336400000,1793343600000]],"highLimit":12.54,"lowLimit":10.26,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":385748938,"isCdr":false,"pbRate":4.05,"roa":"--","peRate":76.882079,"roe":"4.62%","epsLYR":0.0794,"committee":0.168998,"marketValue":4452000000,"turnoverRate":0.1881,"status":0,"floatMarketCap":3295000000},"requestUrl":"/m/hq/s/300404","defaultTab":"news","newsList":[{"id":"2679626252","title":"博济医药（300404）10月30日主力资金净买入1365.60万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2679626252","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679626252?lang=zh_cn&edition=full","pubTime":"2026-10-30 15:32","pubTimestamp":1793345579,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月30日收盘，博济医药报收于11.54元，上涨1.23%，换手率18.81%，成交量53.71万手，成交额6.15亿元。10月30日的资金流向数据方面，主力资金净流入1365.6万元，占总成交额2.22%，游资资金净流入2561.39万元，占总成交额4.16%，散户资金净流出3926.99万元，占总成交额6.38%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000033637.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300404","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679220124","title":"博济医药（300404）10月29日主力资金净买入3078.21万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2679220124","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679220124?lang=zh_cn&edition=full","pubTime":"2026-10-29 15:29","pubTimestamp":1793258969,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月29日收盘，博济医药报收于11.4元，上涨1.88%，换手率11.82%，成交量33.75万手，成交额3.85亿元。10月29日的资金流向数据方面，主力资金净流入3078.21万元，占总成交额8.0%，游资资金净流入1631.08万元，占总成交额4.24%，散户资金净流出4709.29万元，占总成交额12.24%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102900033407.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","300404"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679419310","title":"股市必读：博济医药三季报 - 第三季度单季净利润同比增长90.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679419310","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679419310?lang=zh_cn&edition=full","pubTime":"2026-10-29 04:07","pubTimestamp":1793218054,"startTime":"0","endTime":"0","summary":"业绩披露要点财务报告博济医药2026年三季报显示，前三季度公司主营收入7.32亿元，同比上升25.24%；归母净利润4929.55万元，同比上升124.95%；扣非净利润3230.26万元，同比上升115.62%；其中2026年第三季度，公司单季度主营收入2.78亿元，同比上升24.58%；单季度归母净利润1209.5万元，同比上升90.65%；单季度扣非净利润991.15万元，同比上升231.17%；负债率35.59%，投资收益1274.9万元，财务费用32.49万元，毛利率24.66%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102900004192.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300404"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678451708","title":"10月28日博济医药涨7.29%，国证2000ETF广发基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2678451708","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678451708?lang=zh_cn&edition=full","pubTime":"2026-10-28 16:51","pubTimestamp":1793177512,"startTime":"0","endTime":"0","summary":"证券之星消息，10月28日博济医药涨7.29%，收盘报11.19元，换手率10.1%，成交量28.83万手，成交额3.17亿元。重仓博济医药的公募基金请见下表：该股最近90天内共有1家机构给出评级，增持评级1家。根据2026基金Q3季报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为广发基金的国证2000ETF广发。国证2000ETF广发的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102800036849.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300404","BK0216","399303","159628"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678175781","title":"博济医药(300404)9月30日股东户数4.15万户，较上期增加53.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678175781","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678175781?lang=zh_cn&edition=full","pubTime":"2026-10-27 18:50","pubTimestamp":1793098238,"startTime":"0","endTime":"0","summary":"证券之星消息，近日博济医药披露，截至2026年9月30日公司股东户数为4.15万户，较6月30日增加1.45万户，增幅为53.54%。在医疗服务行业个股中，博济医药股东户数低于行业平均水平，截至9月30日，医疗服务行业平均股东户数为4.74万户。从股价来看，2026年6月30日至2026年9月30日，博济医药区间涨幅为68.15%，在此期间股东户数增加1.45万户，增幅为53.54%。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102700035269.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300404","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678136365","title":"股市必读：博济医药新发布《北京市康达律师事务所关于博济医药科技股份有限公司2026年度向特定对象发行股票的法律意见书》","url":"https://stock-news.laohu8.com/highlight/detail?id=2678136365","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678136365?lang=zh_cn&edition=full","pubTime":"2026-10-26 01:55","pubTimestamp":1792950911,"startTime":"0","endTime":"0","summary":"华泰联合证券有限责任公司关于博济医药科技股份有限公司2026年度向特定对象发行股票之发行保荐书华泰联合证券有限责任公司作为保荐人，为博济医药科技股份有限公司2026年度向特定对象发行股票出具发行保荐书。关于向特定对象发行股票申请获得深圳证券交易所受理的公告博济医药科技股份有限公司于2026年10月22日收到深圳证券交易所出具的通知，其向特定对象发行股票的申请文件已被深交所受理。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102600000560.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300404","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677992870","title":"博济医药（300404）披露2026年度向特定对象发行股票募集说明书（申报稿），10月23日股价上涨0.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2677992870","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677992870?lang=zh_cn&edition=full","pubTime":"2026-10-23 18:07","pubTimestamp":1792750063,"startTime":"0","endTime":"0","summary":"截至2026年10月23日收盘，博济医药报收于11.32元，较前一交易日上涨0.27%，最新总市值为43.67亿元。该股当日开盘11.02元，最高11.42元，最低10.45元，成交额达2.67亿元，换手率为8.56%。博济医药科技股份有限公司于近日披露《2026年度向特定对象发行股票募集说明书（申报稿）》。本次发行方案已获董事会及临时股东大会审议通过，尚需深交所审核通过及证监会注册。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102300033550.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","300404"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677918428","title":"博济医药(300404.SZ)定增股票申请获深交所受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2677918428","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677918428?lang=zh_cn&edition=full","pubTime":"2026-10-23 08:25","pubTimestamp":1792715127,"startTime":"0","endTime":"0","summary":"智通财经APP讯，博济医药(300404.SZ)发布公告，公司于2026年10月22日收到深圳证券交易所(以下简称“深交所”)出具的《关于受理博济医药科技股份有限公司向特定对象发行股票申请文件的通知》(深证上审〔2026〕310号)。深交所对公司报送的向特定对象发行股票的申请文件进行了核对，认为申请文件齐备，决定予以受理。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1511215.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300404","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675804111","title":"股市必读：博济医药新发布《第六届董事会第三次会议决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2675804111","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675804111?lang=zh_cn&edition=full","pubTime":"2026-10-13 01:56","pubTimestamp":1791827773,"startTime":"0","endTime":"0","summary":"截至2026年10月12日收盘，博济医药报收于13.59元，下跌3.69%，换手率9.41%，成交量26.87万手，成交额3.71亿元。公司公告汇总：董事会审议通过《关于公司前次募集资金使用情况专项报告的议案》，确认截至2026年6月30日募集资金使用合规、披露一致，相关专户均已销户。交易信息汇总资金流向10月12日主力资金净流入460.71万元，占总成交额1.24%；游资资金净流入1074.44万元，占总成交额2.89%；散户资金净流出1535.15万元，占总成交额4.13%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101300001885.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","300404"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669450610","title":"博济医药（300404）9月24日主力资金净卖出1.14亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2669450610","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669450610?lang=zh_cn&edition=full","pubTime":"2026-09-24 15:36","pubTimestamp":1790235366,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年9月24日收盘，博济医药报收于14.44元，下跌4.81%，换手率18.23%，成交量52.04万手，成交额7.64亿元。9月24日的资金流向数据方面，主力资金净流出1.14亿元，占总成交额14.99%，游资资金净流出2308.1万元，占总成交额3.02%，散户资金净流入1.38亿元，占总成交额18.01%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400021975.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","300404"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664174308","title":"博济医药（300404）披露完成工商变更登记及备案公告，9月2日股价下跌2.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664174308","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664174308?lang=zh_cn&edition=full","pubTime":"2026-09-02 22:19","pubTimestamp":1788358753,"startTime":"0","endTime":"0","summary":"截至2026年9月2日收盘，博济医药报收于12.68元，较前一交易日下跌2.24%，最新总市值为48.91亿元。近日，博济医药科技股份有限公司披露《关于公司完成工商变更登记及备案的公告》。公司已完成相关工商变更登记及备案手续，取得广州市市场监督管理局换发的《营业执照》，注册资本变更为叁亿捌仟伍佰柒拾肆万捌仟玖佰叁拾捌元，法定代表人王廷春。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090200042858.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300404","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662088550","title":"博济医药：8月26日接受机构调研，中泰证券、鸿运基金等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2662088550","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662088550?lang=zh_cn&edition=full","pubTime":"2026-08-27 21:14","pubTimestamp":1787836440,"startTime":"0","endTime":"0","summary":"证券之星消息，2026年8月27日博济医药发布公告称公司于2026年8月26日接受机构调研，中泰证券、鸿运基金、国金资管、信复创值、招商基金、尚诚资管、红思客、招商证券、国联民生、西部证券、中邮证券、东方证券、华福证券、华鑫证券、银河证券参与。博济医药主营业务：为国内外制药企业及其他研究机构就新药品、医疗器械的研发与生产提供全流程“一站式”CRO服务。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700052311.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600918","BK0276","BK0216","300404"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662792374","title":"博济医药(300404)6月30日股东户数2.7万户，较上期减少13.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662792374","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662792374?lang=zh_cn&edition=full","pubTime":"2026-08-26 17:46","pubTimestamp":1787737601,"startTime":"0","endTime":"0","summary":"证券之星消息，近日博济医药披露，截至2026年6月30日公司股东户数为2.7万户，较3月31日减少4185.0户，减幅为13.4%。在医疗服务行业个股中，博济医药股东户数低于行业平均水平，截至6月30日，医疗服务行业平均股东户数为4.75万户。从股价来看，2026年3月31日至2026年6月30日，博济医药区间跌幅为11.59%，在此期间股东户数减少4185.0户，减幅为13.4%。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082600040179.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","300404"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660348890","title":"博济医药：临床前研究服务包括药物发现、药学研究、非临床安全性评价（GLP）、药效学研究、药代动力学研究等服务","url":"https://stock-news.laohu8.com/highlight/detail?id=2660348890","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660348890?lang=zh_cn&edition=full","pubTime":"2026-08-17 15:45","pubTimestamp":1786952713,"startTime":"0","endTime":"0","summary":"证券之星消息，博济医药(300404)08月17日在投资者关系平台上答复投资者关心的问题。投资者提问：请问贵司临床前哪些业务可以平替药明康德？博济医药回复：您好，公司临床前研究服务包括：药物发现、药学研究、非临床安全性评价（GLP）、药效学研究、药代动力学研究等服务。感谢您的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081700015841.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","300404"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659611036","title":"8月14日博济医药（300404）龙虎榜数据：机构净买入4939.99万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2659611036","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659611036?lang=zh_cn&edition=full","pubTime":"2026-08-14 17:41","pubTimestamp":1786700506,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2026年8月14日公布的交易公开信息显示，博济医药因日涨幅达到15%的前5只证券，连续三个交易日内，涨幅偏离值累计达到30%的证券登上龙虎榜。此次是近5个交易日内第2次上榜。截至2026年8月14日收盘，博济医药报收于17.34元，上涨20.0%，已连续涨停2天，换手率27.53%，成交量78.61万手，成交额13.2亿元。从龙虎榜公布的当日买卖数据来看，机构合计净买入4939.99万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081400029888.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300404","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659715881","title":"8月13日博济医药（300404）龙虎榜数据：机构净买入3657.72万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2659715881","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659715881?lang=zh_cn&edition=full","pubTime":"2026-08-13 17:36","pubTimestamp":1786613806,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2026年8月13日公布的交易公开信息显示，博济医药因日涨幅达到15%的前5只证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2026年8月13日收盘，博济医药报收于14.45元，上涨20.02%，涨停，换手率21.43%，成交量61.19万手，成交额8.23亿元。从龙虎榜公布的当日买卖数据来看，机构合计净买入3657.72万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081300029150.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300404","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659182933","title":"异动快报：博济医药（300404）8月13日9点57分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2659182933","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659182933?lang=zh_cn&edition=full","pubTime":"2026-08-13 10:05","pubTimestamp":1786586732,"startTime":"0","endTime":"0","summary":"证券之星8月13日盘中消息，9点57分博济医药（300404）触及涨停板。其所属行业医疗服务目前上涨。领涨股为博济医药。该股为创新药，干细胞，减肥药概念热股，当日创新药概念上涨2.15%，干细胞概念上涨2.11%，减肥药概念上涨2.0%。8月12日的资金流向数据方面，主力资金净流出2871.15万元，占总成交额4.77%，游资资金净流出2732.44万元，占总成交额4.54%，散户资金净流入5603.59万元，占总成交额9.31%。近5日资金流向一览见下表：博济医药主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081300010238.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","300404"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659689182","title":"生物科技板块拉升 博济医药涨超10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2659689182","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659689182?lang=zh_cn&edition=full","pubTime":"2026-08-13 09:49","pubTimestamp":1786585772,"startTime":"0","endTime":"0","summary":"生物科技板块拉升 博济医药涨超10%","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608133840135180.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608133840135180.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0216","ARTY","XLK","BK4585","300404","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651469721","title":"博济医药（300404）披露2026年第二次临时股东大会通知，7月15日股价上涨3.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651469721","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651469721?lang=zh_cn&edition=full","pubTime":"2026-07-15 22:11","pubTimestamp":1784124673,"startTime":"0","endTime":"0","summary":"截至2026年7月15日收盘，博济医药报收于10.25元，较前一交易日上涨3.12%，最新总市值为39.54亿元。该股当日开盘9.8元，最高10.7元，最低9.75元，成交额达4.18亿元，换手率为14.17%。近日，博济医药科技股份有限公司披露《关于召开2026年第二次临时股东会的通知》。公告显示，公司将于2026年7月31日召开2026年第二次临时股东会，会议采取现场表决与网络投票相结合方式，股权登记日为2026年7月27日。中小投资者表决将单独计票并披露。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071500044715.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","300404"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647557827","title":"博济医药（300404）披露高级管理人员辞职公告，6月30日股价下跌2.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2647557827","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2647557827?lang=zh_cn&edition=full","pubTime":"2026-06-30 22:43","pubTimestamp":1782830595,"startTime":"0","endTime":"0","summary":"博济医药科技股份有限公司近日披露《关于高级管理人员辞职的公告》。公告显示，公司董事会于近日收到副总经理左联女士的书面辞职报告，因个人原因，左联女士申请辞去公司副总经理职务，辞职后不再担任公司其他职务。左联女士的离任自2026年6月30日起生效，原定任期至2026年8月2日。截至公告日，左联女士持有公司股票98,000股，无未履行承诺，离任后将按规定继续遵守股份减持相关法律法规。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026063000047395.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","300404"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1793448970840,"stockEarnings":[{"period":"1week","weight":0.0194},{"period":"1month","weight":-0.2166},{"period":"3month","weight":0.2612},{"period":"6month","weight":0.0761},{"period":"1year","weight":0.1866},{"period":"ytd","weight":0.2387}],"compareEarnings":[{"period":"1week","weight":-0.0248},{"period":"1month","weight":-0.0633},{"period":"3month","weight":-0.0609},{"period":"6month","weight":-0.1248},{"period":"1year","weight":-0.0973},{"period":"ytd","weight":-0.0932}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"博济医药科技股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"41518人(较上一季度增加53.54%)","perCapita":"6876股","listingDate":"2015-04-24","address":"广东省广州市黄埔区科学城南翔一路62号(二、三、四、五)栋","registeredCapital":"38574万元","survey":" 博济医药科技股份有限公司的主营业务是为国内外制药企业及其他研究机构就新药品、医疗器械的研发与生产提供全流程“一站式”CRO服务。公司的主要产品是临床研究服务、临床前研究服务、其他咨询服务、CDMO服务、自主研发及技术成果转化。","listedPrice":12.87},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"博济医药(300404)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供博济医药(300404)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"博济医药,300404,博济医药股票,博济医药股票老虎,博济医药股票老虎国际,博济医药行情,博济医药股票行情,博济医药股价,博济医药股市,博济医药股票价格,博济医药股票交易,博济医药股票购买,博济医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"博济医药(300404)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供博济医药(300404)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}